Matthew Caple

Matt has over 30 years of experience in biopharmaceutical development and operations. Prior to Brammer, he served as Director of Cell Culture Development at Gallus/Patheon Biologics, where he was responsible for the development and/or tech transfer of over 20 phase I-III programs. Prior to joining Patheon, Matt worked as a Director of the Cell Sciences Development group for Sigma-Aldrich, where he led a team of over 50 scientists and worked on over 30 different molecules or cell systems.